Literature DB >> 25559643

Promiscuous 2-aminothiazoles (PrATs): a frequent hitting scaffold.

Shane M Devine1, Mark D Mulcair, Cael O Debono, Eleanor W W Leung, J Willem M Nissink, San Sui Lim, Indu R Chandrashekaran, Mansha Vazirani, Biswaranjan Mohanty, Jamie S Simpson, Jonathan B Baell, Peter J Scammells, Raymond S Norton, Martin J Scanlon.   

Abstract

We have identified a class of molecules, known as 2-aminothiazoles (2-ATs), as frequent-hitting fragments in biophysical binding assays. This was exemplified by 4-phenylthiazol-2-amine being identified as a hit in 14/14 screens against a diverse range of protein targets, suggesting that this scaffold is a poor starting point for fragment-based drug discovery. This prompted us to analyze this scaffold in the context of an academic fragment library used for fragment-based drug discovery (FBDD) and two larger compound libraries used for high-throughput screening (HTS). This analysis revealed that such "promiscuous 2-aminothiazoles" (PrATs) behaved as frequent hitters under both FBDD and HTS settings, although the problem was more pronounced in the fragment-based studies. As 2-ATs are present in known drugs, they cannot necessarily be deemed undesirable, but the combination of their promiscuity and difficulties associated with optimizing them into a lead compound makes them, in our opinion, poor scaffolds for fragment libraries.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25559643     DOI: 10.1021/jm501402x

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  28 in total

1.  How to Triage PAINS-Full Research.

Authors:  Jayme L Dahlin; Michael A Walters
Journal:  Assay Drug Dev Technol       Date:  2015-10-23       Impact factor: 1.738

2.  Post-HTS case report and structural alert: Promiscuous 4-aroyl-1,5-disubstituted-3-hydroxy-2H-pyrrol-2-one actives verified by ALARM NMR.

Authors:  Jayme L Dahlin; J Willem M Nissink; Subhashree Francis; Jessica M Strasser; Kristen John; Zhiguo Zhang; Michael A Walters
Journal:  Bioorg Med Chem Lett       Date:  2015-08-10       Impact factor: 2.823

3.  Identification of novel Trypanosoma cruzi prolyl oligopeptidase inhibitors by structure-based virtual screening.

Authors:  Hugo de Almeida; Vincent Leroux; Flávia Nader Motta; Philippe Grellier; Bernard Maigret; Jaime M Santana; Izabela Marques Dourado Bastos
Journal:  J Comput Aided Mol Des       Date:  2016-10-21       Impact factor: 3.686

Review 4.  Twenty years on: the impact of fragments on drug discovery.

Authors:  Daniel A Erlanson; Stephen W Fesik; Roderick E Hubbard; Wolfgang Jahnke; Harren Jhoti
Journal:  Nat Rev Drug Discov       Date:  2016-07-15       Impact factor: 84.694

5.  Consideration of Binding Kinetics in the Design of Stapled Peptide Mimics of the Disordered Proteins Eukaryotic Translation Initiation Factor 4E-Binding Protein 1 and Eukaryotic Translation Initiation Factor 4G.

Authors:  Erin E Gallagher; James M Song; Arya Menon; Lauren D Mishra; Alyah F Chmiel; Amanda L Garner
Journal:  J Med Chem       Date:  2019-05-09       Impact factor: 7.446

6.  Protein-Observed Fluorine NMR Is a Complementary Ligand Discovery Method to 1H CPMG Ligand-Observed NMR.

Authors:  Andrew K Urick; Luis Pablo Calle; Juan F Espinosa; Haitao Hu; William C K Pomerantz
Journal:  ACS Chem Biol       Date:  2016-10-05       Impact factor: 5.100

7.  2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry.

Authors:  Elisa Azzali; Miriam Girardini; Giannamaria Annunziato; Marialaura Pavone; Federica Vacondio; Giorgia Mori; Maria Rosalia Pasca; Gabriele Costantino; Marco Pieroni
Journal:  ACS Med Chem Lett       Date:  2020-06-08       Impact factor: 4.345

Review 8.  Antimalarial drug discovery targeting apical membrane antigen 1.

Authors:  Shane M Devine; Christopher A MacRaild; Raymond S Norton; Peter J Scammells
Journal:  Medchemcomm       Date:  2016-11-04       Impact factor: 3.597

9.  Fragment-Based Protein-Protein Interaction Antagonists of a Viral Dimeric Protease.

Authors:  Jonathan E Gable; Gregory M Lee; Timothy M Acker; Kaitlin R Hulce; Eric R Gonzalez; Patrick Schweigler; Samu Melkko; Christopher J Farady; Charles S Craik
Journal:  ChemMedChem       Date:  2016-01-28       Impact factor: 3.466

10.  Design, synthesis and antimycobacterial activity of hybrid molecules combining pyrazinamide with a 4-phenylthiazol-2-amine scaffold.

Authors:  Jan Zitko; Ondřej Jand'ourek; Pavla Paterová; Lucie Navrátilová; Jiří Kuneš; Jarmila Vinšová; Martin Doležal
Journal:  Medchemcomm       Date:  2018-02-22       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.